Estradiol in Severe Asthma with Premenstrual Worsening

Annals of Pharmacotherapy

Volumn 37, Issue 11, 2003, Pages 1610-1613

  Ensom, Mary H H ^a,c   Chong, Gina ^a   Beaudin, Bev ^b   Bai, Tony R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Estradiol; Estrogen; Premenstrual asthma

Indexed keywords

ALENDRONIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BUDESONIDE; CORTICOSTEROID; EOSINOPHIL PROTEIN X; ESTRADIOL; LEUKOTRIENE E4; OMEPRAZOLE; PLACEBO; PREDNISONE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MENSTRUAL CYCLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ASTHMA; ESTRADIOL; FEMALE; HUMANS; LUTEAL PHASE; MIDDLE AGED;

EID: 0142151439     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D090     Document Type: Article

References (29)

1. Frank RT. The hormonal causes of pre-menstrual tension. Arch Neurol Psychiatry 1931;26:1053-7.
2. Enright T, Lim DT, Devnani R, Mariano R. Cyclical exacerbations of bronchial asthma. Ann Allergy 1987;58: 405-6.
3. Gibbs CJ, Coutts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984;39: 833-6.
4. Chandler MHH, Schuldheisz S, Phillips BA, Muse KM. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997;17:224-34.
5. Nakasato H, Ohrui T, Seldzawa K, Matsui T, Yamaya M, Tamura G, et al. Prevention of severe premenstrual attacks by leukotriene receptor antagonist. J Allergy Clin Immunol 1999;104:585-8.
6. Ensom MHH, Chong E, Carter D. Premenstrual symptoms in females with premenstrual asthma. Pharmacotherapy 1999;19:374-82.
7. Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs 2001;61:2079-86.
8. Oguzulgen IK, Turktas H, Erbas D. Airway inflammation in premenstrual asthma. J Asthma 2002;39:517-22.
9. Eliasson O, Scherzer HH, DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986;77:87-93.
10. Ensom MHH, Chong G, Zhou D, Beaudin B, Shalansky S, Bai TR. Double-blind randomized, placebo-controlled, crossover study of estradiol in premenstrual asthma. Pharmacotherapy 2003;23:561-71.
11. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999;161(11 suppl):S1-61.
12. National Institutes of Health, National Heart, Lung, and Blood Institute. Expert Panel Report 2 Clinical Practice Guidelines. Guidelines for the Diagnosis and Management of Asthma. NIH publication no. 97-4051. July 1997. www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (accessed 2003 Apr 7).
13. Ng TP. Validity of symptom and clinical measures of asthma severity for primary outpatient assessment of adult asthma. Br J Gen Pract 2000;50:7-12.
14. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-7.
15. Leroyer C, Lebrun T, Proust A, Lenne X, Lucas E, Rio G, et al. Knowledge, self-management, compliance and quality of life in asthma: a cross-sectional study of the French version of the Asthma Quality of Life Questionnaire. Qual Life Res 1998;7:267-72.
16. Ottanelli R, Rosi E, Romagnoli I, Ronchi MC, Lanini B, Grazzini M, et al. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clin Sci 2000;98:681-7.
17. Bheekie A, Syce JA, Weinberg EG. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies. J Clin Pharm Ther 2001;26:287-96.
18. Horak E, Grassi G, Skladal D, Ulmer H. Lung function and symptom perception in children with asthma and their parents. Pediatr Pulmonol 2003;35:23-8.
19. Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol 2003;111:491-7.
20. Cullen DL, Rodak B. Clinical utility of measures of breathlessness. Respir Care 2002;47:986-93.
21. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147:832-8.
22. Kon OM, Sihra BS, Compton CH, Leonard TB, Kay AB, Barnes NC. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 1998;352: 1109-13.
23. Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000;55:260-5.
24. Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients. Ann Allergy Asthma Immunol 2002;88:488-93.
25. Bensch G, Berger WE, Blokhin BM, Socolovsky AL, Thomson MH, Till MD, et al. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma. Ann Allergy Asthma Immunol 2002;89:180-90.
26. Juniper EF, Kline PA, Roberts RS, Hargreave FE, Daniel EE, Airway responsiveness to methacholine during the natural menstrual cycle and effect of oral contraceptives. Am Rev Respir Dis 1987;135:1039-42.
27. Beynon HLC, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;2:370-2.
28. Ozkaragoz K, Cakin F. The effect of menstruation on immediate skin reactions in patients with respiratory allergy. J Asthma Res 1970;7:171-5.
29. Spilker B. Single-patient clinical trials. In: Guide to clinical trials. Philadelphia: Lippincott-Raven, 1996:277-82.